157 related articles for article (PubMed ID: 28710387)
1. Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells.
Van Den Ham KM; Smith LK; Richer MJ; Olivier M
Sci Rep; 2017 Jul; 7(1):5478. PubMed ID: 28710387
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
[TBL] [Abstract][Full Text] [Related]
3. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
4. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis.
Van Den Ham KM; Shio MT; Rainone A; Fournier S; Krawczyk CM; Olivier M
PLoS One; 2015; 10(3):e0118451. PubMed ID: 25768944
[TBL] [Abstract][Full Text] [Related]
5. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
6. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
7. Phenylhydrazine administration accelerates the development of experimental cerebral malaria.
Zhu X; Liu J; Feng Y; Pang W; Qi Z; Jiang Y; Shang H; Cao Y
Exp Parasitol; 2015 Sep; 156():1-11. PubMed ID: 26005191
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
9. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
Lepenies B; Pfeffer K; Hurchla MA; Murphy TL; Murphy KM; Oetzel J; Fleischer B; Jacobs T
J Immunol; 2007 Sep; 179(6):4093-100. PubMed ID: 17785848
[TBL] [Abstract][Full Text] [Related]
10. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease.
Hermsen C; van de Wiel T; Mommers E; Sauerwein R; Eling W
Parasitology; 1997 Jan; 114 ( Pt 1)():7-12. PubMed ID: 9011069
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria.
Gun SY; Claser C; Teo TH; Howland SW; Poh CM; Chye RRY; Ng LFP; Rénia L
Cell Microbiol; 2018 May; 20(5):e12819. PubMed ID: 29281764
[TBL] [Abstract][Full Text] [Related]
12. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
Nie CQ; Bernard NJ; Schofield L; Hansen DS
Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
14. NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria.
Hansen DS; Bernard NJ; Nie CQ; Schofield L
J Immunol; 2007 May; 178(9):5779-88. PubMed ID: 17442962
[TBL] [Abstract][Full Text] [Related]
15. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
[TBL] [Abstract][Full Text] [Related]
16. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
17. CD8
Ghazanfari N; Gregory JL; Devi S; Fernandez-Ruiz D; Beattie L; Mueller SN; Heath WR
J Immunol; 2021 Sep; 207(6):1578-1590. PubMed ID: 34400523
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.
Van den Steen PE; Deroost K; Van Aelst I; Geurts N; Martens E; Struyf S; Nie CQ; Hansen DS; Matthys P; Van Damme J; Opdenakker G
Eur J Immunol; 2008 Apr; 38(4):1082-95. PubMed ID: 18383042
[TBL] [Abstract][Full Text] [Related]
19. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
20. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo.
Haque A; Best SE; Amante FH; Mustafah S; Desbarrieres L; de Labastida F; Sparwasser T; Hill GR; Engwerda CR
PLoS Pathog; 2010 Dec; 6(12):e1001221. PubMed ID: 21170302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]